Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Anxiety Disorders × Dronabinol × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 2 Vomiting 1 Parasomnias 1 Pancreatic Neoplasms 1 Neoplasms 1 Nausea 1 Colonic Neoplasms 1 Cancer Pain 1 Breast Neoplasms 1 Anxiety Disorders 1

Interventions

Music Therapy 5 Cognitive Behavioral Therapy 5 Standard of Care 4 Saline Solution 4 Hypnosis 4 Esketamine 4 Therapeutics 3 Psilocybin 3 Surveys and Questionnaires 2 Palliative Care 2 Ketamine 2 Electroacupuncture 2 Educational Status 2 Cannabidiol 2 Art Therapy 2 nabiximols 1 Waiting Lists 1 Transcutaneous Electric Nerve Stimulation 1 Transcranial Direct Current Stimulation 1 Timbre Perception 1 TEMPO 1 Sertraline 1 Self-Help Groups 1 Selective Serotonin Reuptake Inhibitors 1 Respiration 1 Psychotherapy 1 Psychiatric Rehabilitation 1 Propofol 1 Population Groups 1 Pharmaceutical Preparations 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03948074 2025-09-10

CAFCARS

British Columbia Cancer Agency

Phase 2 Completed

Anxiety Disorders, Nausea, Pain, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡